Physician profile
John E Martin
NPI 1316016819
$1,411.75
in general payments reported to CMS, 2019-2025
17 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $140 · 2021: $156 · 2022: $157 · 2023: $188 · 2024: $269 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $473.61 | 2019-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Abbvie INC. | $268.71 | 2021-2025 | |
| Solventum Corporation | $100.78 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Granufoam |
| Kerecis Limited | $96.47 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Organogenesis INC. | $88.90 | 2021-2025 | Apligraf, Puraply |
| Melinta Therapeutics, LLC | $82.36 | 2019-2020 | |
| Allergan, INC. | $44.70 | 2020 | |
| Kci USA, INC. | $42.88 | 2021-2023 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Aroa Biosurgery Incorporated | $40.21 | 2020-2023 | |
| Next Science LLC | $39.87 | 2023 | Surgx, Blastx, Xperience |
| Molnlycke Health Care US, LLC | $29.84 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $19.28 | 2020 | |
| Nuo Therapeutics | $19.17 | 2025 | |
| Ethicon US, LLC | $18.60 | 2019 | |
| Mimedx Group, INC. | $18.43 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15.81 | 2025 | Tcc-Ez |
| Cashflow Solutions, LLC | $12.13 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.